CSPC PHARMACEUT.GR. ADR4 Tangible Net Worth Ratio
CSPC PHARMACEUT.GR. ADR4 tangible net worth ratio. CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Tangible Net Worth Ratio of 92.4% as of June 2026. This metric is calculated by deducting intangible assets (€2.99 Billion) from net assets (€39.43 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CSPC PHARMACEUT.GR. ADR4 (CVGU) net asset quality to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Tangible net worth ratio of CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. This chart shows how CSPC PHARMACEUT.GR. ADR4's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 92.4%, reflecting net assets of €39.43 Billion with intangible assets of €2.99 Billion EUR. See how liquid is CSPC PHARMACEUT.GR. ADR4's working capital to evaluate short-term liquidity relative to the company's equity base.
CSPC PHARMACEUT.GR. ADR4 Tangible Net Worth Ratio by Year (2021–2025)
CSPC PHARMACEUT.GR. ADR4 tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of CSPC PHARMACEUT.GR. ADR4.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | €34.55 Billion | €2.77 Billion | €46.70 Billion | ▼ -0.3 pp |
| 2024 | 92.3% | €33.87 Billion | €2.61 Billion | €44.39 Billion | ▼ -1.4 pp |
| 2023 | 93.7% | €35.02 Billion | €2.20 Billion | €46.28 Billion | ▼ -0.2 pp |
| 2022 | 94.0% | €31.64 Billion | €1.91 Billion | €41.77 Billion | ▼ -4.3 pp |
| 2021 | 98.3% | €26.83 Billion | €467.85 Million | €34.74 Billion | — |